Core Insights - The article discusses the investment potential in certain biotech stocks, emphasizing the importance of due diligence for investors [2][3] Group 1: Investment Opportunities - The article highlights that some stocks mentioned may already be part of various model portfolios, indicating their potential attractiveness for investors [2] - It notes that small-cap and biotech stocks carry a higher risk of losses compared to the broader market, which is crucial for investors to consider [2] Group 2: Market Trends and Performance - The article mentions that opinions on stocks can change over time with new data, suggesting that investors should stay informed about market trends [2] - It emphasizes that past performance is not a guarantee of future results, which is a critical reminder for investors evaluating potential investments [3]
Cidara Therapeutics: A Potential Blockbuster In Flu Prevention (NASDAQ:CDTX)